ARCHIVES

Slamon, Sherr Win Landon-AACR Prizes

This article is from The Cancer Letter archive.

Vol. 29 No. 10 | March 7, 2003

Download PDF Visit The Full Archive

Related Articles

NIH News: Board of Governors Appointed to Oversee Clinical Center

October 24, 1996

Afinitor and Exemestane More Than Doubles PFS, Reduces Progression Risk by 57 Percent

September 30, 2011

US Oncology Renegotiates Agreements To Operate Under Net Earnings Model.

March 30, 2001

Motesanib Does Not Improve OS; Study Doesn’t Meet Primary Endpoint

April 29, 2011

ACCC Established FCCC Special Interest Group

April 11, 1986

Neutron Therapy “Treatment Of Choice” In Salivary Gland Tumors – 100 Percent Complete Reponses

June 13, 1986